HCPCS Level II
J2360
Injection, orphenadrine citrate, up to 60 mg
Codes near J2360
These sit next to J2360 in the CMS Level II file. All J codes
- J2355Injection, oprelvekin, 5 mg
- J2356Injection, tezepelumab-ekko, 1 mg
- J2357Injection, omalizumab, 5 mg
- J2358Injection, olanzapine, long-acting, 1 mg
- J2359Injection, olanzapine, 0.5 mg
- J2361Injection, depemokimab-ulaa, 1 mg
- J2370Injection, phenylephrine hcl, up to 1 ml
- J2371Injection, phenylephrine hydrochloride, 20 micrograms
- J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
- J2373Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00641-6182-10 | Orphenadrine Citrate Injection | Hikma Pharmaceuticals USA Inc. | 10 |
| 00641-6182-25 | Orphenadrine Citrate Injection | Hikma Pharmaceuticals USA Inc. | 25 |
| 25021-0651-02 | Orphenadrine Citrate Injection | Sagent Pharmaceuticals | 10 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.